Change in COVID-19 risk over time following vaccination with CoronaVac: A testnegative case-control study.

Saved in:
Bibliographic Details
Title: Change in COVID-19 risk over time following vaccination with CoronaVac: A testnegative case-control study.
Authors: Hitchings MDT; Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA., Ranzani OT; Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.; Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil., Lind ML; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Dorion M; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., D'Agostini TL; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil., de Paula RC; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil., de Paula OFP; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil., de Moura Villela EF; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil., Torres MSS; Municipal Health Secretary of Manaus, Brazil, AM, Brazil., de Oliveira SB; Pan American Health Organization, Brasília, DF, Brazil.; Universidade de Brasília, Brasília, DF, Brazil., Schulz W; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA., Almiron M; Pan American Health Organization, Brasília, DF, Brazil., Said R; Pan American Health Organization, Brasília, DF, Brazil., de Oliveira RD; State University of Mato Grosso do Sul - UEMS, Dourados, MS, Brazil., da Silva PV; Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil., de Araújo WN; Pan American Health Organization, Brasília, DF, Brazil.; Universidade de Brasília, Brasília, DF, Brazil.; National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, RS, Brazil., Gorinchteyn JC; Health Secretariat of the State of São Paulo, São Paulo, Brazil., Dean NE; Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA., Cummings DAT; Department of Biology, University of Florida, Gainesville, FL, USA.; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., Ko AI; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil., Croda J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil.
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Dec 24. Date of Electronic Publication: 2021 Dec 24.
Publication Type: Preprint; Journal Article
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.1101/2021.12.23.21268335